{"url_path":"/sec/ocul/8-k/2026-06-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1393434/0001104659-26-073496-index.html","accession_number":"0001104659-26-073496","cik":"0001393434","ticker":"OCUL","issuer_name":"OCULAR THERAPEUTIX, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1393434/0001104659-26-073496-index.html","primary_entity_key":"0001393434","primary_entity_name":"OCULAR THERAPEUTIX, INC"},"word_count":103,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits:\n\n \n\n[99.1](https://www.sec.gov/ix?doc=/Archives/edgar/data/1393434/000110465926053176/ocul-20260611xdef14a.htm)\n[Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, incorporated herein by reference to Appendix B to the Company’s definitive proxy statement, filed with the Securities and Exchange Commission on April 30, 2026.](https://www.sec.gov/ix?doc=/Archives/edgar/data/1393434/000110465926053176/ocul-20260611xdef14a.htm)\n\n \n \n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \nOCULAR THERAPEUTIX, INC.\n\n \n \n \n\nDate: June 12, 2026\nBy:\n/s/ Jason S. Robins\n\n \n \nJason S. Robins\n\n \n \nChief Financial Officer"}